LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A) Clinical Trials

5 clinical trials for LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A) across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Preclinical Assessment of an Engineered HMGB1 Protein as a Novel Companion Therapy for Muscular Dystrophies — RECRUITING
• Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy — RECRUITING
• Characterization of the Natural History of LAMA2-RD and Identification of Novel Disease Biomarkers — RECRUITING
• Spanish Natural History Study for LAMA2 Muscular Dystrophy — RECRUITING
• LAMA2-related Muscular Dystrophy Brain Study — WITHDRAWN

Refine this search